Cyclophosphamide/fludarabine nonmyeloablative allotransplant for acute myeloid leukemia

E-ISSN： 1096-8652|90|2|97-99

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.90, Iss.2, 2015-02, pp. : 97-99

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Facts about FCE (Fludarabine, Cytarabine, Etoposide) in Acute Myeloid Leukemia

Acta Haematologica, Vol. 131, Iss. 4, 2013-11 ,pp. : 200-201

Karger

Access to resources Recommend Favorite

The Combination of Fludarabine, Cytarabine and Etoposide Is an Active and Well-Tolerated Regimen in Relapsed/Refractory Acute Myeloid Leukemia

Acta Haematologica, Vol. 131, Iss. 4, 2013-11 ,pp. : 202-207

Karger

Access to resources Recommend Favorite

Reduced‐intensity conditioning with fludarabine and busulfan versus fludarabine and melphalan for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

CANCER, Vol. 121, Iss. 7, 2015-04 ,pp. : 1048-1055

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Pilot Study of Busulfan, Cyclophosphamide and Etoposide Followed by Autologous Transplantation for Acute Myeloid Leukemia in Remission

Acta Haematologica, Vol. 104, Iss. 2-3, 2001-01 ,pp. : 144-147

Karger

Access to resources Recommend Favorite

Immunotherapy in acute myeloid leukemia

CANCER, Vol. 121, Iss. 16, 2015-08 ,pp. : 2689-2704

John Wiley & Sons Inc

Access to resources Recommend Favorite